Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies

for
Solid Tumor
Location: Rochester MN, San Antonio TX, Phoenix AZ
Sponsor: Athenex, Inc.

Sex: All

Age: 18+

Code: NCT02963168

Phase 1, Recruiting

A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

for
Obesity, Malignant Neoplasm
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 13 - 30

Code: NCT04453072

Recruiting

Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

for
Unspecified Adult Solid Tumor, Protocol Specific
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT00992303

Recruiting

Effectiveness of Central Oncology Navigation and the Use of an ORN

for
Cancer, Malignant Tumor
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06618274

Recruiting

Promoting Physical Activity In After-School Programs for Urban Adolescents

for
Unspecified Adult Solid Tumor, Protocol Specific
Location: Montclair NJ
Sponsor: Montclair State University

Sex: All

Age: 11 - 14

Code: NCT00301158

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: New York NY, Fairfax VA, Toronto, Orlando FL,
Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All

Age: 18+

Code: NCT06307795

Phase 1, Recruiting

Young Adult Infusion Space Experience Satisfaction Survey

for
Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18 - 39

Code: NCT05720546

Recruiting

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

for
Head and Neck Cancer, Relapse, Recurrent, Refractory Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06096038

Phase 1, Recruiting

Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers

for
Metastatic Malignant Solid Neoplasm
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06606990

Phase 1, Recruiting

A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849

for
Advanced Solid Tumor
Location: Fairfax VA, Cleveland OH, Dallas TX, San Antonio TX,
Sponsor: 1ST Biotherapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05761223

Phase 1, Phase 2, Recruiting

UNC Childhood, Adolescent, and Young Adult Cancer Cohort

for
Pediatric Cancer, Cancer, Cancer Metastatic, Survivorship
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 1 - 39

Code: NCT05096923

Recruiting

Exercise and Relaxation Intervention for Young Adult Cancer Survivors

for
Cancer
Location: Providence RI
Sponsor: The Miriam Hospital

Sex: All

Age: 18 - 39

Code: NCT00801008

Recruiting

The Effects of Case Management in a Medicaid Managed Care Plan

for
Neoplasms, Heart Diseases, Adrenal Cortex Diseases
Location: Brooklyn NY
Sponsor: Metropolitan Jewish Health System

Sex: All

Age: 18+

Code: NCT00385879

Recruiting

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

for
Malignant Neoplasm
Location: Jersey City NJ, New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 1+

Code: NCT02688517

Recruiting

Study of ACR-2316 in Specific Advanced Solid Tumors

for
Specific Advanced Solid Tumors
Location: Boston MA, Providence RI, The Bronx NY, Fairfax VA,
Sponsor: Acrivon Therapeutics

Sex: All

Age: 18+

Code: NCT06667141

Phase 1, Phase 2, Recruiting

A Phase I Open-label Study for Subjects With Advanced Malignancies

for
Advanced Solid Malignancies
Location: Jacksonville FL, Rochester MN, Phoenix AZ
Sponsor: Athenex, Inc.

Sex: All

Age: 18+

Code: NCT04136834

Phase 1, Recruiting

Efficacy of a Digestive Enzyme Blend

for
Digestive Health, Indigestion, Protein Digestion,
Location: Kennesaw GA
Sponsor: Deerland Enzymes

Sex: All

Age: 18 - 55

Code: NCT04917913

Recruiting

Dabrafenib and/or Trametinib Rollover Study

for
Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers,
Location: Toronto
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT03340506

Phase 4, Recruiting

Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan (NYU 99-32)

for
Cancer
Location: New York NY
Sponsor: National Center for Research Resources (NCRR)

Sex: All

Age: 18+

Code: NCT00006199

Phase 1, Recruiting

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

for
Malignant Solid Neoplasm
Location: Marshalltown IA, Ames IA, Boone IA, Fort Dodge IA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04871542

Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial